Synonym: 6-[(3,4-Dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl]-3-pyridinecarboxylic acid ethyl ester; AGN-190168; ethyl 6-[2-(4,4-dimethylthiochroman-6-yl)ethynyl] nicotinate
CAS Number: 118292-40-3
Empirical Formula (Hill Notation): C21H21NO2S
Molecular Weight: 351.46
Linear Formula: C21H21NO2S
Product Type: Chemical
This image is provided for informative purposes only and does not represent an actual product label. It should not be used as a substitute for official product labeling.
This picture is provided solely for illustration purposes, it may have been created or edited with AI. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material.
This image depicts T7080-50MG.
| assay |
≥98% (HPLC) |
| color |
white to very faintly yellow |
| form |
powder |
| InChI |
1S/C21H21NO2S/c1-4-24-20(23)16-7-9-17(22-14-16)8-5-15-6-10-19-18(13-15)21(2,3)11-12-25-19/h6-7,9-10,13-14H,4,11-12H2,1-3H3 |
| InChI key |
OGQICQVSFDPSEI-UHFFFAOYSA-N |
| originator |
Allergan |
| Quality Level |
100  |
| SMILES string |
S1CCC(c2c1ccc(c2)C#Cc3ncc(cc3)C(=O)OCC)(C)C |
| solubility |
DMSO: >15 mg/mL |
| storage temp. |
2-8°C |
| Biochem/physiol Actions: |
Tazarotene induces the expression of tazarotene-induced gene 3 (TIG3), a tumor suppressor gene. |
| Biochem/physiol Actions: |
Tazarotene induces the expression of tazarotene-induced gene 3 (TIG3), a tumor suppressor gene. It is a prodrug of tazarotenic acid, which specifically activates RARb and RARg, only weakly activates RARa, and is inactive at retinoid X receptors (RXRs). In psoriasis, tazarotene normalizes abnormal keratinocyte differentiation and reduces their hyperproliferation. |
| Features and Benefits: |
This compound is a featured product for Gene Regulation research. Click here to discover more featured Gene Regulation products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm . |
| Features and Benefits: |
This compound was developed by Allergan . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: |
10, 50 mg in glass bottle |
| Purity |
≥98% (HPLC) |
| Storage Temp. |
2-8°C |
| UNSPSC |
12352200 |